markboulton’s Twitter Archive—№ 30,632

@jhuskisson @emmaboulton So, whilst, yes, standardisation and buying power of the NHS can (and does) lower costs. The move to generic medicines is not advantageous to every patient. This is a delicate subject because it affects me directly.